Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

40.8K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
Bone Disorders01:29

Bone Disorders

5.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.1K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

5.9K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.9K
Nucleosome Remodeling02:54

Nucleosome Remodeling

11.5K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-level expression of a newly characterized collagenase in Bacillus subtilis for efficient production of collagen peptides from fish scales.

Food chemistry·2026
Same author

Engineered haptoglobin β fusion protein targets myoglobin and ameliorates rhabdomyolysis-associated acute kidney injury.

EMBO molecular medicine·2026
Same author

Efficacy and Safety of TRPV1 Antagonists for Atopic Dermatitis: A Systematic Review and Meta-Analysis Focusing on Asivatrep.

International journal of dermatology·2026
Same author

Income, diet, and cognitive function: observational analyses and candidate metabolomic pathways identified by Mendelian randomization.

The journal of prevention of Alzheimer's disease·2026
Same author

Bone marrow mesenchymal stem cells have tissue-specific characteristic in promoting the potential of periodontal ligament stem cells for periodontal regeneration.

Journal of advanced research·2026
Same author

2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota Modulation and Involvement of the LPS/TLR4 Signaling.

Journal of agricultural and food chemistry·2026

Related Experiment Video

Updated: Mar 9, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Epigenetics, Bone Remodeling and Osteoporosis.

Shaoqing Yang, Xiaohong Duan1

  • 1State Key Laboratory of Military Stomatology, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Oral Diseases, Department of Oral Biology, Clinic of Oral Rare and Genetic Diseases, School of Stomatology, The Fourth Military Medical University, Xi`an, 710032, People`s Republic of China.

Current Stem Cell Research & Therapy
|December 23, 2016
PubMed
Summary

Epigenetic regulation influences bone health and osteoporosis. This review covers epigenetic mechanisms in bone development and potential drug therapies for osteoporosis.

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.0K
Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
05:25

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.0K
Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
05:25

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

2.0K

Area of Science:

  • Molecular Biology
  • Genetics
  • Bone Biology

Background:

  • Epigenetic modifications (DNA, histones, non-coding RNAs) regulate gene expression and heritable traits without altering DNA sequence.
  • Epigenetic regulation is crucial for bone homeostasis, influencing osteoblast, osteoclast, and osteocyte differentiation and function.
  • Osteoporosis, characterized by reduced bone strength and increased fracture risk, is linked to abnormal bone metabolism, particularly osteoclast dysfunction.

Purpose of the Study:

  • To review current understanding of epigenetic regulation in bone development and remodeling.
  • To highlight the role of epigenetic alterations in osteoporosis pathogenesis.
  • To explore the therapeutic potential of epigenetic drugs for treating osteoporosis.

Main Methods:

  • Literature review of recent studies on epigenetics and bone biology.
  • Analysis of research linking epigenetic mechanisms to bone homeostasis and osteoporosis.
  • Examination of preclinical and clinical data on epigenetic therapies for bone diseases.

Main Results:

  • Epigenetic mechanisms are integral to normal bone development and maintenance.
  • Aberrant epigenetic regulation, especially affecting osteoclast function, contributes significantly to osteoporosis.
  • Emerging evidence supports the efficacy of epigenetic drugs in preclinical models of osteoporosis.

Conclusions:

  • Epigenetic regulation is a key determinant of bone health and disease.
  • Targeting epigenetic pathways offers a promising therapeutic strategy for osteoporosis.
  • Further research is warranted to fully elucidate epigenetic mechanisms and optimize drug development for osteoporosis.